Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Absorption-Distribution-Metabolism-Excretion Toxicity
10%
Adverse Effect
9%
Antiinfective Agent
8%
Antioxidant
12%
Apigenin
10%
Astragalus
13%
Biocompatibility
10%
Biological Marker
11%
Breast Cancer
13%
Carbon Dioxide
10%
Carcinogenesis
8%
Cardiotoxicity
10%
Cardiovascular Disease
11%
Chemotherapy Regimen
10%
Chitosan
28%
Cisplatin
13%
Clopidogrel
13%
Combination Therapy
9%
Controlled Release
8%
CYP2C9
8%
Diabetes Mellitus
24%
Diseases
38%
Doxorubicin
26%
Drug Delivery System
24%
Hemoglobin A1c
10%
High Performance Liquid Chromatography
8%
Hyaluronic Acid
15%
Liposome
13%
Liver Cell Carcinoma
21%
Liver Enzyme
13%
Lung Cancer
10%
Malignant Neoplasm
100%
microRNA
57%
Nanomaterial
12%
Nanoparticle
13%
Neoplasm
31%
Pharmacokinetic
8%
Polysaccharide
17%
Prostate Cancer
13%
Quercetin
10%
Rat
17%
Resveratrol
10%
SARS Coronavirus
13%
Silibinin
13%
Silymarin
14%
Superoxide Dismutase
9%
Tablet
12%
Tumor Growth
10%
Untranslated RNA
12%
Warfarin
23%
Biochemistry, Genetics and Molecular Biology
Adeno Associated Virus
8%
Allele
6%
Angiotensin-Converting Enzyme
6%
Anticancer
11%
Aptamer
13%
Autophagy
8%
Cancer Cell
14%
Carcinogenesis
7%
Cohort Study
6%
Comorbidity
6%
CYP2C9
13%
Drug Resistance
5%
Gene Polymorphism
6%
Gene Vector
6%
Genetic Risk
6%
Genotyping
13%
Indel
6%
Isoform
5%
JAK-STAT Signaling
6%
Kexin
6%
MERTK
6%
Mesenchymal-Epithelial Transition
5%
MicroRNA
36%
Mugil cephalus
6%
Myeloid
6%
Non-Coding RNA
13%
Osmoregulation
6%
Oxidoreductase
6%
Phase I Trials
6%
Physiological Process
5%
Programmed Cell Death
14%
Proprotein Convertase
6%
Reductase
6%
Retinitis pigmentosa
13%
RNA
9%
Single Nucleotide Polymorphism
6%
Stem Cell
7%
Subtilisin
6%
Tumor Progression
9%
Virus Gene
6%
Vitamin K Epoxide Reductase
10%
Medicine and Dentistry
Adeno-Associated Virus
7%
Apigenin
6%
Breast Cancer
16%
Cancer Cell
11%
Cancer Inhibition
7%
Cancer Therapy
11%
Combination Therapy
5%
Diabetes Mellitus
5%
Doxorubicin
10%
Drug Therapy
6%
Epithelial Mesenchymal Transition
6%
Exosome
6%
Gene Therapy
6%
Gene Vector
6%
Glycon
6%
Hepatocellular Carcinoma
6%
Injection
5%
Lung Cancer
13%
Malignant Neoplasm
15%
Meta-Analysis
6%
Metastatic Carcinoma
9%
microRNA
16%
Neoplasm
11%
Ophthalmology
10%
Ophthalmomyiasis
6%
Phase I Trials
6%
Plant Extract
6%
Programmed Cell Death
9%
Prostate Cancer
6%
Restylane
6%
Retinitis pigmentosa
10%
Silymarin
6%
Subretinal Drug Administration
6%
Systematic Review
13%
Tumor Progression
5%
Virus Gene
6%
Visual Acuity
5%